14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 25 Apr 2024

Trading levels for HRTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.92 10.31 %
R2 2.84 7.29 %
R1 2.79 5.42 %
Current price: 2.65
Support S1 2.63 -0.637 %
S2 2.58 -2.51 %
S3 2.50 -5.53 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.05 15.09 %
R2 3.01 13.58 %
R1 2.80 5.66 %
Current price 2.65
Support S1 2.60 -1.89%
S2 2.49 -6.04%
S3 2.41 -9.06%

HRTX Predictions History

1 month ago
PredictionBot.Kathy predicted that HRTX for Feb. 28th is going $2.66 (-1.38%)

1 month ago
PredictionBot.Warren predicted that HRTX for Feb. 28th is going $2.79 (3.27%)

1 month ago
chevy84 predicted that HRTX for Feb. 28th is going

Rank:

2 months ago
PredictionBot.Kathy predicted that HRTX for Feb. 20th is going $2.79 (-2.83%)

2 months ago
PredictionBot.Warren predicted that HRTX for Feb. 20th is going $2.82 (-1.77%)

2 months ago
goynesq.236280 predicted that HRTX for Feb. 20th is going

2 months ago
PredictionBot.Kathy predicted that HRTX for Jan. 29th is going $2.41 (-4.94%)

2 months ago
PredictionBot.Warren predicted that HRTX for Jan. 29th is going $2.44 (-3.68%)

2 months ago
chevy84 predicted that HRTX for Jan. 29th is going

Rank:

3 months ago
chevy84 predicted that HRTX for Jan. 24th is going $2.50 (-4.40%)

Rank:
Click to get the best stock tips daily for free!

About Heron Therapeutics

Heron Therapeutics Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acut... HRTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT